X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-16 | MBX | Sandell Scott D | 10% | P - Purchase | $16.00 | +500,000 | 3,614,486 | +16% | +$8,000,000 | |||||
2024-04-22 | KRRO | Sandell Scott D | 10% | P - Purchase | $56.00 | +17,857 | 1,090,793 | +2% | +$999,992 | ||||||
2023-11-20 | NET | Sandell Scott D | Dir | S - Sale | $73.17 | -211,534 | 217,859 | -49% | -$15,477,312 | ||||||
| D | 2023-08-08 | NET | Sandell Scott D | Dir | S - Sale+OE | $65.26 | -20,307 | 439,676 | -4% | -$1,325,158 | |||||
2023-07-17 | SVRA | Sandell Scott D | 10% | P - Purchase | $3.00 | +333,333 | 24,471,264 | +1% | +$999,999 | ||||||
| M | 2023-01-25 | GLYC | Sandell Scott D | 10% | S - Sale | $3.14 | -3,652,016 | 4,967,530 | -42% | -$11,484,515 | |||||
2023-01-05 | GLYC | Sandell Scott D | 10% | S - Sale | $2.76 | -71,362 | 8,619,546 | -1% | -$196,859 | ||||||
| M | 2022-12-30 | GLYC | Sandell Scott D | 10% | S - Sale | $2.98 | -398,133 | 8,690,908 | -4% | -$1,185,886 | |||||
2022-12-23 | ACLX | Sandell Scott D | 10% | S - Sale | $31.67 | -390 | 4,746,494 | 0% | -$12,353 | ||||||
2022-12-21 | ACLX | Sandell Scott D | 10% | S - Sale | $30.74 | -179 | 4,746,884 | 0% | -$5,502 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |